A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization

Vaccine

Volumn 26, Issue 50, 2008, Pages 6441-6444

  Shiota, Seiji ^a   Khawplod, Pakamatz ^b   Ahmed, Kamruddin ^c   Mifune, Kumato ^a   Nishizono, Akira ^a,c  

^a OITA UNIVERSITY   (Japan)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c Institute of Scientific Research   (Japan)

Author keywords

Intradermal regimen; Japan; Rabies vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RABIES; SIDE EFFECT; SKIN; VACCINATION; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; JAPAN; MALE; NEUTRALIZATION TESTS; PILOT PROJECTS; RABIES; RABIES VACCINES; RABIES VIRUS; TREATMENT OUTCOME; VACCINATION; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 55749086989     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.068     Document Type: Article

References (15)

1. Steffen R., Banon A., and deBernardis C. Vaccination priorities. Int J Antimicrob Agents 21 (2003) 175-180
2. Takayama N. Rabies control in Japan. Jpn J Infect Dis 53 3 (2000) 93-97
3. WHO Expert Committee on Rabies. Technical Report 931. Geneva, Switzerland: WHO; 2005.
4. World Health Organization. WHO Recommendations on Rabies Post-Exposure Treatment and the Correct Technique of Intradermal Immunization Against Rabies. Geneva, Switzerland: WHO; 1997.
5. Arai Y.T., Kimura M., Sakaue Y., Hamada A., Yamada K., Nakayama M., et al. Antibody responses induced by immunization with a Japanese rabies vaccine determined by neutralization test and enzyme-linked immunosorbent assay. Vaccine 20 (2002) 2448-2453
6. Tamashiro H., Matibag G.C., Ditangco R.A., Kanda K., and Ohbayashi Y. Revisiting rabies in Japan: Is there cause for alarm?. Travel Med Infect Dis 5 5 (2007) 263-275
7. Smith J.S., Yager P.A., and Baer G.M. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies. 4th ed. (1996), Geneva, WHO 181-192
8. Benjavongkulchai M., Kositprapa C., Limsuwun K., Khawplod P., Thipkong P., Chomchey P., et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan. Vaccine 15 (1997) 1816-1819
9. WHO Expert Committee on Rabies. Eighth Report. World Health Organ Tech Rep Ser 1992; series 824.
10. Lau C., and Sisson J. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 9 6 (2002) 285-288
11. Shaw M.M., Leggat P.A., and Williams M.L. Intradermal pre-exposure rabies immunization in New Zealand. Travel Med Infect Dis 4 1 (2006) 29-33
12. Infectious Agents Surveillance Report. Rabies as of 2006, Japan. March 2007. 28:3:3. [cited 29 April 2007. Available at URL:/http://idsc.nih.go.jp/iasr/28/325/tpc325.htmlS.
13. Takayama N. Study on the subjects received post-exposure rabies vaccination in our vaccine clinic. Kansenshogaku Zasshi. 69 1 (1995) 73-78 [in Japanese]
14. Sudarshan M.K., Mahendra B.J., Madhusudana S.N., Narayana D.H., Sanjay T.V., Gangaboraiah, et al. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Human Vaccine 1 5 (2005) 187-190
15. Khawplod P., Wilde H., Benjavongkulchai M., Sriaroon C., and Chomchey P. Immunogenicity study of abbreviated rabies preexposure vaccination schedules. J Travel Med. 14 (2007) 173-176